|
Emerillon Therapeutics
416 de Maisonneuve West
Suite 1000
Montreal, Quebec H3A 1L2
Canada
Phone: (514) 985-0306
Fax: (514) 985-0012
Email:
|
Emerillon Therapeutics is a genomics-based drug discovery company. They use their recombinant congenic strains of mice to dissect human diseases.
- History:
Emerillon Therapeutics starred out life as RGS Genome. They were acquired by Xenon Biosearch (now known as Xenon Pharmaceuticals) in 2000 and then spun back out in 2003 (which is when they acquired the name Emerillon Therapeutics).
Acquisitions:
HemaX Genome (2005)
|
